84 patents
Page 4 of 5
Utility
Humanized antibodies that recognize alpha-synuclein
28 Dec 20
The present application discloses humanized 1H7 antibodies.
Jose Saldanha, Tarlochan S. Nijjar
Filed: 18 Feb 20
Utility
Antibodies recognizing alpha-synuclein
28 Dec 20
The invention provides monoclonal antibody 5C1 and related antibodies.
Robin Barbour, Kate Dora Games Thiel, Tarlochan S. Nijjar
Filed: 22 Apr 20
Utility
Methods for detecting phosphorylated alpha-synuclein
30 Nov 20
The invention provides methods of detecting alpha-synuclein using a capture antibody and a reporter antibody.
Robin Barbour, Lynn R. Zieske, Sarah Hamren
Filed: 24 Aug 16
Utility
Antibodies Recognizing Tau
25 Nov 20
The invention provides antibodies that specifically bind tau.
Tarlochan S. Nijjar, Robin BARBOUR, Philip James DOLAN, III, Yue LIU, Svetlana ALEXANDER, Mark RENZ
Filed: 2 Mar 20
Utility
Lyophilized Formulation of a Monoclonal Antibody Against Transthyretin
18 Nov 20
The invention provides antibody formulations and methods useful for prophylaxis or treatment of transthyretin-related amyloidosis.
Jay SOTO, Andrea HAWE, Ruedeeporn TANTIPOLPHAN, Stefan HEINDL
Filed: 27 Nov 18
Utility
Anti-transthyretin Antibodies
21 Oct 20
The invention provides antibodies that specifically bind to transthyretin (TTR).
Joshua Reginald SALMANS, Svetlana ALEXANDER, Robin BARBOUR, Jeffrey N. HIGAKI, Tarlochan S. NIJJAR
Filed: 4 Oct 18
Utility
Antibodies Recognizing Alpha-synuclein
7 Oct 20
The invention provides monoclonal antibody 5C1 and related antibodies.
Robin Barbour, Kate Dora Games Thiel, Tarlochan S. Nijjar
Filed: 22 Apr 20
Utility
Methods of Treating Al Amyloidosis
30 Sep 20
Antibody formulations and methods useful for treatment of patients with AL amyloidosis.
Gene KINNEY, Carol KARP, Wagner Marcelo ZAGO, Radhika TRIPURANENI
Filed: 4 Mar 20
Utility
Anti-transthyretin Antibodies
2 Sep 20
The invention provides antibodies that specifically bind to transthyretin (TTR).
Tarlochan S. Nijjar, Avijit Chakrabartty, Jeffrey N. Higaki
Filed: 11 Feb 20
Utility
Humanized Antibodies That Recognize Alpha-Synuclein
2 Sep 20
The present application discloses humanized 1H7 antibodies.
Jose Saldanha, Tarlochan S. Nijjar
Filed: 18 Feb 20
Utility
Tau immunotherapy
24 Aug 20
The invention provides antibodies to tau.
Peter Seubert, Philip James Dolan, III, Yue Liu, Robin Barbour
Filed: 1 May 17
Utility
Methods of Detecting Transthyretin
5 Aug 20
The invention provides methods of detecting transthyretin (TTR) using a capture antibody and a reporter antibody.
Joshua Reginald SALMANS, Svetlana ALEXANDER, Robin BARBOUR, Jianmin LI, Jeffrey N. HIGAKI, Tarlochan S. NIJJAR
Filed: 4 Oct 18
Utility
Humanized antibodies that recognize alpha-synuclein
27 Jul 20
The present application discloses humanized 9E4 antibodies.
Jose William Saldanha, Tarlochan S. Nijjar
Filed: 19 May 19
Utility
Anti-MCAM Antibodies And Associated Methods Of Use
8 Jul 20
Described herein are anti-MCAM antibodies and antigen binding fragments thereof that are capable of inhibiting the interaction between MCAM and its ligand, a protein comprising a laminin α-4 chain.
Kenneth Flanagan, Jeanne Baker, Theodore A. Yednock
Filed: 15 Jan 20
Utility
Anti-transthyretin antibodies
1 Jun 20
The invention provides antibodies that specifically bind transthyretin (TTR).
Yue Liu, Tarlochan S. Nijjar, Avijit Chakrabartty, Jeffrey N. Higaki
Filed: 11 Sep 18
Utility
Antibodies recognizing α-synuclein
1 Jun 20
The invention provides monoclonal antibody 5C1 and related antibodies.
Robin Barbour, Kate Dora Games Thiel, Tarlochan S. Nijjar
Filed: 15 Apr 19
Utility
Mcam Antagonists and Methods of Treatment
27 May 20
Described herein are MCAM antagonists, including MCAM antagonist antibodies capable of inhibiting the interaction between MCAM and it ligand, a laminin a4 chain, e.g., an ct4 chain of laminin 41 1.
Kenneth Flanagan, Jennifer Johnston, Theodore Yednock, Jeanne Baker
Filed: 20 Nov 19
Utility
Anti-laminin4 antibodies specific for LG4-5
18 May 20
The invention provides antibodies that specifically bind to the LG4-5 modules of the G domain of laminin α4.
Stephen Jed Tam, Yue Liu, Robin Barbour, Theodore Yednock, Kenneth Flanagan
Filed: 28 May 18
Utility
Antibody Formulations and Methods
6 May 20
The invention provides antibody formulations and methods useful for prophylaxis or treatment of synucleinopathies, including Parkinson's disease.
Patrick Garidel, Andreas Langer, Michael Grundman
Filed: 31 Oct 19
Utility
Anti-transthyretin antibodies
27 Apr 20
The invention provides antibodies that specifically bind to transthyretin (TTR).
Tarlochan S. Nijjar, Avijit Chakrabartty, Jeffrey N. Higaki
Filed: 1 Jul 16